Evidence-aware probiotic product reviews Educational information • Not medical advice
Home  ›  Reviews  ›  Align Probiotic Review
Product Review

Align Probiotic Review: 35624 Strain, Evidence & Safety

Align 24/7 Digestive Support has one major advantage over many generic probiotic blends: its core strain has actually been studied in humans. That does not mean every marketing claim is proven, and the clinical evidence is more nuanced than the brand’s advertising suggests.

Updated August 15, 2026 Current formula + human trials reviewed
Our verdict

A credible single-strain probiotic—but not a guaranteed digestive fix

Align is easier to take seriously than products that hide behind giant CFU numbers and unnamed blends. The 35624 strain has randomized human trials behind it, the label identifies the strain, and the product is shelf-stable. The limitation is that the evidence is mixed across populations: positive IBS trials do not prove the same degree of benefit for otherwise healthy people with occasional bloating or gas.

What we like

  • Single named strain with human clinical research.
  • Once-daily dosing.
  • No refrigeration required.
  • Current label clearly states CFU at manufacture and through best-by date.
  • Gluten-free and vegetarian according to Align.
  • More transparent than many proprietary multi-strain blends.

What to keep in perspective

  • Not every trial showed meaningful symptom improvement versus placebo.
  • Manufacturer recommendation rankings are survey/marketing claims, not efficacy trials.
  • Contains milk/sodium caseinate according to Align’s current safety FAQ.
  • CFU declines over shelf life.
  • It is a dietary supplement, not an FDA-approved IBS treatment.
  • Benefits cannot be generalized to every person with gas or bloating.

What exactly is in Align 24/7 Digestive Support?

The current official supplement-facts label identifies the active microorganism as Bifidobacterium longum subsp. longum 35624™. Older studies and older Align materials commonly call the same trademarked strain Bifidobacterium infantis 35624 or simply Bifidobacterium 35624.

Current label itemWhat it saysWhy it matters
Probiotic strainB. longum subsp. longum 35624™The strain—not merely the species—is the level most closely tied to the clinical evidence.
Amount10 mg per capsuleMass is less useful than viable CFU when judging a live probiotic.
CFU at manufacture1 × 109 (1 billion)This is the starting viable count listed on the current official label.
Guaranteed through best-by1 × 107 (10 million)The viable count can fall substantially during shelf life.
Serving1 capsule dailyAlign states it can be taken with or without food.
StorageRoom temperatureNo refrigeration is required when stored as directed.

The current label also lists microcrystalline cellulose, hypromellose, magnesium stearate, and titanium dioxide among the other ingredients. Align’s current safety FAQ additionally states that the product contains milk and sodium caseinate (milk protein) and may contain trace lactose.

Milk allergy matters here. The product may be vegetarian and gluten-free, but that does not make it dairy-free. Align specifically advises people with milk allergy or milk-protein concerns to consult a healthcare professional.

What is Bifidobacterium 35624?

Bifidobacterium 35624 is a specific probiotic strain originally isolated from the gastrointestinal tract of a healthy human. The old review incorrectly described it as “engineered” to survive the digestive tract. It was not presented by the manufacturer as a genetically engineered strain.

It also should not be described as permanently establishing colonies in the gut. A study that tracked fecal excretion during and after supplementation found that levels of B. infantis 35624 increased during use and then declined toward baseline after supplementation stopped—evidence of transient rather than permanent colonization.

What do the human trials actually show?

2006 randomized trial in 362 women with IBS

Positive at one dose

Participants received placebo or B. infantis 35624 at 106, 108, or 1010 CFU for four weeks. The 108 CFU dose was significantly better than placebo for abdominal pain/discomfort and several secondary IBS symptoms. The lower and higher doses were not significantly different from placebo; the highest-dose formulation also had technical problems.

2005 randomized trial in 77 adults with IBS

Positive

B. infantis 35624 was associated with lower scores for abdominal pain/discomfort, bloating/distention, and bowel-movement difficulty compared with placebo during much of the eight-week study. This was delivered in a malted-milk drink at 1010 live cells, so it was not the same final dosage form as today’s capsule.

2017 randomized trial in 302 non-patients with bloating/discomfort

Mixed / mostly negative

At 109 CFU daily for four weeks, both placebo and probiotic groups improved. There was no significant difference in mean abdominal-discomfort or bloating severity at the end of treatment. The probiotic group did have more bloating-free days. Both regimens were well tolerated.

2022 real-world IBS study

Observational

An open-label multicenter study of adults with Rome IV IBS reported improvement in IBS severity and quality of life after 30 days of B. longum 35624 at 109 CFU daily. Because there was no placebo control, it is supportive but weaker evidence than a blinded randomized trial.

The dose question is more complicated than Align marketing suggests

One of the strongest lessons from the 2006 trial is that probiotic effects can be dose-specific. The 108 CFU dose performed better than placebo, while 106 did not and the 1010 formulation did not demonstrate the same benefit.

The current Align label states 1 billion CFU at manufacture and guarantees 10 million CFU through the best-by date. Align calls that end-of-shelf-life level effective, but it is worth noticing that the guaranteed count at the end of shelf life is below the 108 CFU dose that performed best in the 2006 capsule trial. That does not prove the retail product is ineffective; it does mean consumers should not assume the CFU printed “at manufacture” is the exact viable dose present months later.

Does Align help IBS?

The most defensible answer is: Bifidobacterium 35624 has human evidence for improving IBS symptoms, but Align is not an FDA-approved IBS drug and results are not guaranteed.

The positive 2005 and 2006 randomized trials are meaningful, particularly because they used the named 35624 strain rather than an unspecified probiotic blend. However, IBS is heterogeneous, current clinical guidelines do not treat all probiotics as interchangeable, and later research has not produced uniformly positive results in every population.

If you have persistent abdominal pain, major changes in bowel habits, blood in stool, unexplained weight loss, fever, anemia, or symptoms that wake you from sleep, do not use a supplement review as a substitute for medical evaluation.

Does Align help occasional bloating and gas?

This is where the marketing is stronger than the cleanest clinical conclusion. Align currently promotes 35624 for occasional bloating, gas, and abdominal discomfort. But in the 2017 randomized trial specifically enrolling people with chronic bloating/discomfort who were not IBS patients, mean severity did not improve significantly more than placebo. The probiotic did increase the number of bloating-free days.

So a fair review should say the strain may help some people, not that relief is predictable or that “4 out of 5” marketing language proves symptom efficacy.

What about the “#1 doctor recommended” claim?

Align currently advertises itself as the probiotic brand most recommended by physicians and gastroenterologists. That may be useful evidence of brand recognition and professional familiarity, but it is not a clinical endpoint.

A recommendation survey does not tell you how much a specific patient’s bloating improved, whether the product beat placebo, or whether Align is clinically superior to every competing probiotic. We treat the claim as marketing context—not proof of medical effectiveness.

How easy is Align to use?

DosingOnce dailyAlign says one capsule per day, with or without food.
StorageRoom temperatureNo refrigeration required when stored according to the label.
FormulaSingle strainEasier to connect the product to strain-specific research than a large proprietary blend.

If you are unsure whether morning or evening is better, see our Best Time to Take Probiotics guide. For most users, following the product directions consistently is more important than chasing a universal clock time.

Potential side effects and safety

Align states that clinical studies found no significant difference in side effects between Align and placebo, while some users report temporary gas or bloating during the first few days. More broadly, NIH notes that probiotic side effects in healthy people are usually mild and gastrointestinal.

People who are severely ill or immunocompromised should discuss probiotics with a healthcare professional because rare systemic infections have been reported with probiotic organisms in high-risk patients. Align also advises asking a healthcare professional before use during pregnancy or breastfeeding.

See our full Side Effects of Probiotics guide for a broader safety discussion.

Who is Align best suited for?

  • Adults who prefer a single, clearly identified strain rather than a giant multi-strain blend.
  • People who value a probiotic with randomized human studies behind the strain.
  • Those who want a once-daily, shelf-stable capsule.
  • People willing to judge the product by their own symptom response rather than expecting guaranteed results.

Who might want to skip it?

  • Anyone with a milk-protein allergy or concern about the milk/sodium caseinate listed by Align.
  • People expecting a supplement to diagnose or treat unexplained gastrointestinal symptoms.
  • Someone specifically looking for a multi-strain product or a probiotic studied for another condition.
  • People who are severely ill or immunocompromised unless their healthcare professional thinks probiotic use is appropriate.
  • Anyone expecting a doctor-recommendation survey to guarantee that the product will work for them.

Where to buy Align 24/7 Digestive Support

Align is sold in several package sizes. Compare the current price per capsule and confirm that the listing is for 24/7 Digestive Support with Bifidobacterium 35624, because Align now sells several different probiotic formulas.

Affiliate disclosure: As an Amazon Associate, ProbioticsAdvice.org may earn from qualifying purchases made through the Amazon link at no additional cost to you. Amazon listings and package sizes can change; verify the exact product and strain before ordering.

Align vs. a typical high-CFU probiotic

FeatureAlign 24/7Typical “50–100 billion” blend
Strain transparencyOne clearly identified strain: 35624Varies; some list strains, others only species
Human evidenceMultiple human studies on the named strainDepends heavily on the exact formula
CFU marketingRelatively modest CFU countOften emphasizes very large total CFU
Does more CFU mean better?No. Probiotic benefit is strain-, dose-, product-, and outcome-specific.

This is one reason Align is an instructive product: the 2006 trial itself showed that more CFU was not automatically better. Read How to Choose Probiotics before using total CFU as your main buying criterion.

Align Probiotic Review FAQ

What strain is in Align 24/7 Digestive Support?

The current official label identifies Bifidobacterium longum subsp. longum 35624™. Historical studies and older materials often refer to the same trademarked strain as Bifidobacterium infantis 35624 or Bifidobacterium 35624.

How many CFUs are in Align?

The current official label states 1 billion CFU at manufacture and 10 million viable cells guaranteed through the best-by date.

Does Align need refrigeration?

No. Align says 24/7 Digestive Support can be stored at room temperature when stored according to the package directions.

Can you take Align with food?

Yes. Align’s current instructions say one capsule daily with or without food.

Does Align help IBS?

The 35624 strain has positive randomized trials in IBS, including a 2006 study in which one dose significantly outperformed placebo. That does not make Align an FDA-approved IBS treatment or guarantee that every patient will respond.

Does Align help bloating?

Possibly for some people. A 2017 randomized trial in non-patients with bloating and abdominal discomfort found more bloating-free days with 35624 but no significant improvement over placebo in mean bloating severity.

Is Align dairy-free?

No. Align’s current safety FAQ says the product contains milk and sodium caseinate and may contain trace lactose.

Is Align safe?

It is generally well tolerated in healthy adults, and its trials did not show major safety signals. People who are severely ill, immunocompromised, pregnant, or breastfeeding should discuss use with an appropriate healthcare professional.

Final verdict

Align 24/7 Digestive Support is one of the more defensible mainstream probiotic products because it centers on a clearly identified strain with genuine human research. That is a much stronger foundation than simply putting 10 or 20 species into a capsule and advertising a huge CFU total.

But we would not repeat the old article’s claim that Align “delivers on its promises.” The evidence is more specific: 35624 performed well in some IBS trials, showed mixed results for otherwise healthy people with bloating/discomfort, appears generally well tolerated in healthy adults, and does not permanently colonize the gut.

For someone who wants a simple, once-daily, shelf-stable, single-strain probiotic, Align is a reasonable product to compare. The right expectation is possible digestive benefit—not guaranteed relief.

Newsletter

Get practical gut-health guidance without the hype.

Join the Probiotics Advice newsletter for updated probiotic and prebiotic guides, product reviews, and evidence-aware gut-health reading.

Join the Probiotics Advice newsletter

You can unsubscribe using the link included in newsletter emails.

Probiotics Advice Newsletter